SCHEMBL6951267

SCHEMBL6951267

N#Cc1c(OCC(F)(F)F)nc(NCCOCCO)nc1N1CCc2ccccc2CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KCNH3 Q9ULD8 3/20 0.38
MAPT P10636 4/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
PIK3CD O00329 1/20 0.35
GRIN2D O15399 2/20 0.34
GRIN3B O60391 2/20 0.34
CHRM1 P11229 2/20 0.34
ADRA1D P25100 2/20 0.34
ADRA1A P35348 2/20 0.34
ADRA1B P35368 2/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2A Q12879 2/20 0.34
GRIN2B Q13224 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945704 0.92 GRIN2D (0.41) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6945718 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EMEN1KMT2AKCNH3
SCHEMBL6955488 0.85 AURKA (0.38) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6948041 0.84 ABCC1 (0.41) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6957130 0.83 IDH2 (0.39) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6949140 0.83 PLK1 (0.39) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6949377 0.82 MEN1 (0.42) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6955262 0.81 PIK3CD (0.40) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6952840 0.81 PIK3CD (0.38) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6947660 0.80 OGA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed